Pune, India -- (SBWire) -- 02/01/2019 --In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitous discovery.
Global Cloud Based Drug Discovery Platform Market was value US$ +1Bn in 2018 and is expected to reach US$ +5Bn by 2026 at a CAGR of +14%.
Request Sample Copy of this Report@:
http://www.healthcareintelligencemarkets.com/request_sample.php?id=29785
This report focuses on the global top players, covered
IBM Corporation, Tata Consultancy Services Limited, Accenture PLC, BioXcel Corporation, SAS Institute Inc., and Cloud Pharmaceuticals Inc.
The global market for cloud-based drug discovery platforms is subdivided into pharmaceutical, biotech, contract research and other end-users. The global market for potential drug discovery platforms is also supported by advancing technology development. It helps to add innovative features to users. The cloud-based drug discovery platforms are accessible via notebooks, computers and mobile phones. It is safe and can be maintained by third parties.
The pharmaceutical companies segment is the dominant end-user segment in the cloud-based drug discovery platform market. The ever-increasing demand for a drug from various pharmaceutical companies is expected to drive market growth for the cloud-based drug discovery platform. This report focuses on the status of the global cloud-based drug discovery platform, future predictions, growth opportunities, key markets and key players.
Get Reasonable Discount on this Premium Report @:
http://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=29785
Geographically, the global market for cloud-based drug discovery platforms is widespread in Europe, North America, Latin America, Asia-Pacific, the Middle East and Africa. Western Europe and North America are prominent among them. Several pharmaceutical companies in the region have already deployed a cloud-based drug discovery platform. In the future, more companies are expected to follow.
Major Factors about the Report:
-Global Cloud-based Drug Discovery Platforms Market Overview
-Economic Impact on Market
-Market Competition
-Global Cloud-based Drug Discovery Platforms Market Analysis by Application
-Industrial Chain, Sourcing Strategy and Downstream Buyers
-Marketing Strategy Analysis, Distributors/Traders
-Global Market Effect, Factors, Analysis
-Global Market Forecast
Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
For More Information:
http://www.healthcareintelligencemarkets.com/enquiry_before_buying.php?id=29785
Cloud-Based Drug Discovery Platforms Market Pharmaceutical Vendors Estimated to Be the Most Attractive End User Segment Through 2025
Top key players like IBM Corporation, Tata Consultancy Services Limited, Accenture PLC, BioXcel Corporation, and SAS Institute